Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program
Open Access
- 1 April 2011
- journal article
- Published by Informa UK Limited in Clinical Epidemiology
- Vol. 3 (1), 139-148
- https://doi.org/10.2147/clep.s17191
Abstract
Background: The role of histology in the targeted management of nonsmall cell lung cancer (NSCLC) has garnered renewed attention in recent years. We provide contemporary population-based estimates of survival and an assessment of important prognostic factors in stage IV NSCLC by major histologic subtype. Methods: Using data from the Surveillance, Epidemiology and End Results (SEER) Program, we stratified 51,749 incident stage IV NSCLC patients (1988–2003 with follow-up through 2006) by major histologic subtype. We used Kaplan–Meier and Cox proportional hazards methods to describe overall survival and the prognostic influence of select patient, tumor, and treatment characteristics for each histologic subgroup. Results: Survival was highest in patients with bronchioloalveolar adenocarcinoma (1-year survival: 29.1%) and lowest in those with large cell tumors (1-year survival: 12.8%). Diagnosis in later years, female gender, younger age, either Asian/Pacific Islander or Hispanic race/ethnicity, lower tumor grade, and surgery or beam radiation as part of first-line treatment were generally independently associated with a decreased risk of death, but the prognostic significance of some of these factors (age, ethnicity, tumor grade) varied according to histologic subtype. Conclusion: Findings demonstrate a poor prognosis across histologic subtypes in stage IV NSCLC patients but highlight differences in both absolute survival and the relative importance of select prognostic factors by histologic subclassification. More research using other sources of population-based data could help clarify the role of histology in the presentation, management, and prognosis of late-stage NSCLC.Keywords
This publication has 24 references indexed in Scilit:
- Non-small-cell lung cancer: should histology guide chemotherapy treatment?Annals Of Oncology, 2009
- Lung CancerNew England Journal of Medicine, 2008
- First-Line Chemotherapy for Non–Small-Cell Lung Cancer: Is There a Superior Regimen Based on Histology?Journal of Clinical Oncology, 2008
- Gender differences in non-small cell lung cancer: A population-based studyEuropean Journal of Surgical Oncology, 2007
- Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinomaCancer, 2005
- Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002The Annals of Thoracic Surgery, 2004
- Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 casesAnnals of Oncology, 2002
- Lung cancer in patients under 50 years oldLung Cancer, 2001
- Sex differences in presentation, management, and prognosis of patients with non–small cell lung carcinomaThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Lung Cancer in Patients < 50 Years of AgeChest, 1999